123 related articles for article (PubMed ID: 7445531)
21. The metabolism of ethynodiol diacetate by rat and human liver.
Freudenthal RI; Cook CE; Forth J; Rosenfeld R; Wall ME
J Pharmacol Exp Ther; 1971 May; 177(2):468-73. PubMed ID: 5568802
[TBL] [Abstract][Full Text] [Related]
22. The metabolism and disposition of 14C-indolidan, a potent and orally active cardiotonic agent, in four species of laboratory animals.
Bernstein JR; Franklin RB
Xenobiotica; 1988 Dec; 18(12):1335-45. PubMed ID: 3245229
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences.
Lan SJ; El-Hawey AM; Dean AV; Schreiber EC
Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816
[TBL] [Abstract][Full Text] [Related]
24. The metabolic fate of 14C-ximoprofen in rats, baboons and humans.
Mayo BC; Chasseaud LF; Hawkins DR; Taylor IW; Legeai J
Xenobiotica; 1990 Mar; 20(3):233-46. PubMed ID: 2336835
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
[TBL] [Abstract][Full Text] [Related]
26. Metabolism and excretion of ropivacaine in humans.
Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
[TBL] [Abstract][Full Text] [Related]
27. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.
Bechtel WD; Mierau J; Richter I; Stiasni M
Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579
[TBL] [Abstract][Full Text] [Related]
28. Disposition of bemitradine, a renal vasodilator and diuretic, in man.
Walls CM; Gray A; Vose CW; Robinson Y; Lopez N; Brownsill RD; Steiner JA
Xenobiotica; 1988 Dec; 18(12):1413-23. PubMed ID: 3245233
[TBL] [Abstract][Full Text] [Related]
29. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
30. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
31. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
Timchalk C; Smith FA; Bartels MJ
Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
[TBL] [Abstract][Full Text] [Related]
32. Distribution and metabolism of the antipsychotic agent mazapertine succinate in rats.
Caldwell GW; Wu WN; McKown LA; Diane Gauthier A; Masucci JA; Jones WJ; Leo GC; Reitz AB
J Pharm Biomed Anal; 2006 May; 41(2):500-9. PubMed ID: 16386397
[TBL] [Abstract][Full Text] [Related]
33. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
[TBL] [Abstract][Full Text] [Related]
34. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects.
Hoffmann M; DeMaio W; Jordan RA; Talaat R; Harper D; Speth J; Scatina J
Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869
[TBL] [Abstract][Full Text] [Related]
35. The disposition and metabolism of [14C]fluconazole in humans.
Brammer KW; Coakley AJ; Jezequel SG; Tarbit MH
Drug Metab Dispos; 1991; 19(4):764-7. PubMed ID: 1680653
[TBL] [Abstract][Full Text] [Related]
36. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
37. Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing.
Clarke SE; Austin NE; Bloomer JC; Haddock RE; Higham FC; Hollis FJ; Nash M; Shardlow PC; Tasker TC; Woods FR
Xenobiotica; 1994 Nov; 24(11):1119-31. PubMed ID: 7701853
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacokinetics of AR-L 115 BS in rhesus monkeys (author's transl)].
Mierau J
Arzneimittelforschung; 1981; 31(1a):221-5. PubMed ID: 7195226
[TBL] [Abstract][Full Text] [Related]
39. Isoniazid-induced inhibition in the biotransformation of [14C] diphenylhydantoin in rat.
Buttar HS
Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):35-57. PubMed ID: 905633
[TBL] [Abstract][Full Text] [Related]
40. Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine.
Misra AL; Pontani RB; Vadlamani NL; Mulé SJ
J Pharmacol Exp Ther; 1976 Feb; 196(2):257-68. PubMed ID: 1255476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
